{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:21:55Z","timestamp":1790774515772,"version":"4.1.0"},"reference-count":67,"publisher":"Informa UK Limited","issue":"17","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.2217\/fon-2020-1244","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T05:08:58Z","timestamp":1615525738000},"page":"2127-2140","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":80,"title":["Ezh2 Inhibition by Tazemetostat: Mechanisms of Action, Safety and Efficacy in Relapsed\/refractory Follicular Lymphoma"],"prefix":"10.1080","volume":"17","author":[{"given":"Edith","family":"Julia","sequence":"first","affiliation":[{"name":"Department of Hematology, Hospices Civils de Lyon, H\u00f4pital Lyon-Sud, Pierre-B\u00e9nite, 69310, France"},{"name":"Facult\u00e9 de M\u00e9decine Lyon-Sud, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard, 165, Chemin du Grand Revoyet, Cedex, Oullins, 69495, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9541-8666","authenticated-orcid":false,"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine Lyon-Sud, Universit\u00e9 de Lyon, Universit\u00e9 Claude Bernard, 165, Chemin du Grand Revoyet, Cedex, Oullins, 69495, France"},{"name":"Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY10065, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,3,12]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.420"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0190-8"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2017.1282587"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10351"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00169-2"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2856"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-04-496893"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2017.32"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16159"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.127"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2013.12.027"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.169"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.621"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2013.04.011"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni876"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI70626"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.518"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.311"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1116418109"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-321208"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1012525107"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4092"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0028585"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2016.07.006"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-1090"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.2711"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.04.004"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.09.012"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07853-z"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.01.007"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11606"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1084"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1210371110"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.2139"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.8327"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-822148"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00010"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30089-4"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1314583"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.151738"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.4648"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-05-786566"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30026-2"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1807315"},{"issue":"23","key":"e_1_3_5_47_1","first-page":"2628","article-title":"Venetoclax-rituximab \u00b1 bendamustine vs bendamustine-rituximab in relapsed\/refractory follicular lymphoma: CONTRALTO","volume":"136","author":"Zinzani PL","year":"2020","unstructured":"Zinzani PL , FlinnIW, YuenSLSet al. Venetoclax-rituximab \u00b1 bendamustine vs bendamustine-rituximab in relapsed\/refractory follicular lymphoma: CONTRALTO. Blood136(23), 2628\u20132637 (2020).","journal-title":"Blood"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708566"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-08-867499"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-13-0773"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1303800110"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-16-0840"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30145-1"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2020.01.006"},{"key":"e_1_3_5_55_1","unstructured":"FDA . Tazemetostat - FDA drug prescribing informations. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/211723s000lbl.pdf"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-3741"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30441-1"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7534"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-115132"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI94645"},{"key":"e_1_3_5_61_1","unstructured":"FDA . FDA Briefing Document Oncologic Drugs Advisory Committee Meeting: NDA 211723 tazemetostat applicant epizyme. (2019). https:\/\/www.fda.gov\/media\/133573\/download"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-018-0465-4"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-804344"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2437_126"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111840"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002580"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.9258"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30097-3"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.3656"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2020-1244","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T02:42:53Z","timestamp":1719110573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2020-1244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,12]]},"references-count":67,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["10.2217\/fon-2020-1244"],"URL":"https:\/\/doi.org\/10.2217\/fon-2020-1244","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,12]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-12-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}